Thor Medical ASA (FRA:8NN) Total Equity: €38.53 Mil (As of Dec. 2025)


FRA:8NN Thor Medical ASA FRA:8NN
21 GF Score
Price €0.38
! 2 Warning Signs
View Full Analysis

What is Thor Medical ASA Total Equity?

Thor Medical ASA FRA:8NN +3.51% 21 Total Equity is €38.53 Mil as of Dec. 2025. GuruFocus rates FRA:8NN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Thor Medical ASA's total equity for the quarter that ended in Dec. 2025 was €38.53 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Thor Medical ASA Total Equity Historical Data

* Premium members only.

The historical data trend for Thor Medical ASA's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA Total Equity Chart

Thor Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.85 6.10 23.64 28.70 38.53

Thor Medical ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.64 22.75 28.70 40.84 38.53
FRA:8NN
21GF Score
Thor Medical ASA FRA:8NN
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thor Medical ASA Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Thor Medical ASA's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=59.878-21.347
=38.53

Thor Medical ASA's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=59.878-21.347
=38.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €38.53 Mil mean?
Thor Medical ASA (FRA:8NN) has a Total Equity of €38.53 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Thor Medical ASA and its competitors.
Is Thor Medical ASA's Total Equity too high?
Thor Medical ASA's current Total Equity is €38.53 Mil. Overall, Thor Medical ASA has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Thor Medical ASA's Total Equity compare to VRTX and REGN?
Thor Medical ASA's Total Equity of €38.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Thor Medical ASA and its competitors. Thor Medical ASA's current Total Equity is €38.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thor Medical ASA stock overvalued right now?
Thor Medical ASA (FRA:8NN) has a current Total Equity of €38.53 Mil. The current Total Equity is €38.53 Mil. Thor Medical ASA's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Thor Medical ASA (FRA:8NN), the current Total Equity is €38.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thor Medical ASA Business Description

Other Exchanges TRMED:Norway0R6Y:UK
Address Drammensveien 167, Oslo, NOR, 0277
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.
21GF Score

Get the complete analysis for FRA:8NN

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.38
Price